These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9253411)

  • 1. Picture story. Trimers and tumours.
    Smith T
    Nat Struct Biol; 1997 Aug; 4(8):629. PubMed ID: 9253411
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
    Xu J; Attisano L
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad2 and Smad4 gene mutations in hepatocellular carcinoma.
    Yakicier MC; Irmak MB; Romano A; Kew M; Ozturk M
    Oncogene; 1999 Aug; 18(34):4879-83. PubMed ID: 10490821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Smad activity.
    Wrana JL
    Cell; 2000 Jan; 100(2):189-92. PubMed ID: 10660041
    [No Abstract]   [Full Text] [Related]  

  • 5. Human Smad3 and Smad4 are sequence-specific transcription activators.
    Zawel L; Dai JL; Buckhaults P; Zhou S; Kinzler KW; Vogelstein B; Kern SE
    Mol Cell; 1998 Mar; 1(4):611-7. PubMed ID: 9660945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF beta/Smad signaling system and its pathologic correlates.
    Cohen MM
    Am J Med Genet A; 2003 Jan; 116A(1):1-10. PubMed ID: 12476444
    [No Abstract]   [Full Text] [Related]  

  • 8. The TGF-beta--Smad network: introducing bioinformatic tools.
    Kloos DU; Choi C; Wingender E
    Trends Genet; 2002 Feb; 18(2):96-103. PubMed ID: 11818142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
    De Bosscher K; Hill CS; Nicolás FJ
    Biochem J; 2004 Apr; 379(Pt 1):209-16. PubMed ID: 14715079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of Smad2 recognition by the Smad anchor for receptor activation.
    Wu G; Chen YG; Ozdamar B; Gyuricza CA; Chong PA; Wrana JL; Massagué J; Shi Y
    Science; 2000 Jan; 287(5450):92-7. PubMed ID: 10615055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Smad2 partners bind a common hydrophobic pocket in Smad2 via a defined proline-rich motif.
    Randall RA; Germain S; Inman GJ; Bates PA; Hill CS
    EMBO J; 2002 Jan; 21(1-2):145-56. PubMed ID: 11782434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoserine-dependent regulation of protein-protein interactions in the Smad pathway.
    Wrana JL
    Structure; 2002 Jan; 10(1):5-7. PubMed ID: 11796104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
    Beall MJ; McGonigle S; Pearce EJ
    Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.
    Fiocchi C
    J Clin Invest; 2001 Aug; 108(4):523-6. PubMed ID: 11518725
    [No Abstract]   [Full Text] [Related]  

  • 16. The nuclear import function of Smad2 is masked by SARA and unmasked by TGFbeta-dependent phosphorylation.
    Xu L; Chen YG; Massagué J
    Nat Cell Biol; 2000 Aug; 2(8):559-62. PubMed ID: 10934479
    [No Abstract]   [Full Text] [Related]  

  • 17. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling.
    Wu JW; Hu M; Chai J; Seoane J; Huse M; Li C; Rigotti DJ; Kyin S; Muir TW; Fairman R; Massagué J; Shi Y
    Mol Cell; 2001 Dec; 8(6):1277-89. PubMed ID: 11779503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.
    Huse M; Muir TW; Xu L; Chen YG; Kuriyan J; Massagué J
    Mol Cell; 2001 Sep; 8(3):671-82. PubMed ID: 11583628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction. An anchor for activation.
    ten Dijke P; Heldin CH
    Nature; 1999 Jan; 397(6715):109, 111. PubMed ID: 9923670
    [No Abstract]   [Full Text] [Related]  

  • 20. Signal transduction. Mad about SMADs.
    Wrana J; Pawson T
    Nature; 1997 Jul; 388(6637):28-9. PubMed ID: 9214496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.